Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021)

Creative Medical Technology Holdings has reported Receivables over the past 5 years, most recently at $2485.0 for Q4 2021.

  • Quarterly Receivables changed N/A to $2485.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2485.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $2485.0 for FY2021, N/A changed from the prior year.
  • Receivables was $2485.0 for Q4 2021 at Creative Medical Technology Holdings, up from $1400.0 in the prior quarter.
  • Over five years, Receivables peaked at $24500.0 in Q3 2019 and troughed at $163.0 in Q1 2019.
  • The 5-year median for Receivables is $5200.5 (2017), against an average of $7195.8.
  • Biggest five-year swings in Receivables: plummeted 98.3% in 2019 and later soared 5053.37% in 2020.
  • Tracing CELZ's Receivables over 5 years: stood at $4801.0 in 2017, then skyrocketed by 99.96% to $9600.0 in 2018, then plummeted by 41.67% to $5600.0 in 2019, then tumbled by 75.0% to $1400.0 in 2020, then soared by 77.5% to $2485.0 in 2021.
  • According to Business Quant data, Receivables over the past three periods came in at $2485.0, $1400.0, and $8400.0 for Q4 2021, Q2 2020, and Q1 2020 respectively.